In drug discovery, even after a target protein has been identified for treating a disease, designing a therapeutic molecule that specifically binds that protein remains a staggering challenge. Imagine searching for a single, perfectly shaped key in a warehouse of nearly infinite keys—each with a unique three-dimensional shape. This isn't just a metaphor; for a protein of length ‘n’, there can be 20^n possible sequences, each capable of adopting countless conformations. Since the average human protein is 430 amino acids, this represents 20^430 possible sequences, a practically infinite number and more than the number of atoms in the universe (10^80). This potential diversity is so important in the evolution of life but presents a challenge for researchers. In traditional workflows, this complexity means painstaking trial and error—iterating through thousands of candidates, each synthesis and validation round taking months, if not years. The process is expensive, slow, and fraught with uncertainty. Researchers often use educated guesses and hope that a binder emerges from the colossal search. This blueprint applies generative AI to pre-optimize molecules and screen their interaction with the target protein. This BioNeMo blueprint shows how protein binder design can be recast using NIM microservices for protein folding, structure generation, and sequence generation to speed up the development cycle and produce better binders faster. This blueprint is for research and development only.
GOVERNING HOSTING TERMS: Use of this trial service is governed by the NVIDIA API Trial Terms of Service. Use of this blueprint software is governed by the Apache 2.0, and enables use of separate open source and proprietary software, models, data and services governed by their respective licenses below:
The software components in this blueprint are not owned or developed by NVIDIA. They have been developed and built to a third-party's requirements; see links to Non-NVIDIA Model Cards: OpenFold3, RFdiffusion, and ProteinMPNN.
Global
NVIDIA AI Blueprints are customizable AI workflow examples that equip enterprise developers with NIM microservices, reference code, documentation, and a Helm chart for deployment.
Computational biologists, protein engineers, and drug discovery researchers use this blueprint to design novel protein binders against a target protein of interest. It supports teams exploring generative AI–driven alternatives to slow, expensive trial-and-error binder design workflows in therapeutic protein development and other protein engineering applications.
See a complete example of how to get started with this blueprint on the NVIDIA BioNeMo Blueprints GitHub repository.
RFdiffusion is capable of generating protein backbones, and ProteinMPNN can label the amino acid sequence. The combination yields sequences that should fold into the protein structure that binds to the specified static target protein structure. Note that proteins are flexible and adopt multiple conformations. This is especially true of antibodies where the binding interface is disordered. This poses a challenge for these models.
build.nvidia.com 07/06/2026 via https://build.nvidia.com/nvidia/protein-binder-design-for-drug-discovery
Github 07/06/2026 via https://github.com/NVIDIA-BioNeMo-blueprints/generative-protein-binder-design
2.0.0
Hardware Requirements
OS Requirements
OpenFold3 NIM, RFdiffusion NIM, and ProteinMPNN NIM.
NVIDIA believes Trustworthy AI is a shared responsibility and we have established policies and practices to enable development for a wide array of AI applications. Developers should work with their internal model team to ensure this model meets requirements for the relevant industry and use case and addresses unforeseen product misuse.
Please report blueoprint quality, risk, security vulnerabilities or NVIDIA AI Concerns here.
This blueprint shows how generative AI and accelerated NIM microservices can design protein binders smarter and faster.